Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1413560
This article is part of the Research Topic Community Series in Towards Precision Medicine for Immune-Mediated Disorders: Advances in Using Big Data and Artificial Intelligence to Understand Heterogeneity in Inflammatory Responses, Volume II View all 9 articles

Radiomics-based machine learning model to phenotype hip involvement in ankylosing spondylitis: a pilot study

Provisionally accepted
Zhengyuan Hu Zhengyuan Hu 1Yan Wang Yan Wang 2Xiaojian Ji Xiaojian Ji 1Bo Xu Bo Xu 3Yan Li Yan Li 1Jie Zhang Jie Zhang 1Xingkang Liu Xingkang Liu 1Kunpeng Li Kunpeng Li 1Jianglin Zhang Jianglin Zhang 1Jian Zhu Jian Zhu 1Xin Lou Xin Lou 2*Feng Huang Feng Huang 1*
  • 1 Department of Rheumatology and Immunology, Chinese PLA General Hospital, Beijing, China
  • 2 Department of Radiology, Chinese PLA General Hospital, Beijing, China
  • 3 Basic Research Center for Medical Science, Academy of Medical Science, Zhengzhou University, Zhengzhou, China

The final, formatted version of the article will be published soon.

    Objectives: Hip involvement is an important reason of disability in patients with ankylosing spondylitis (AS). Unveiling the potential phenotype of hip involvement in AS remains an unmet need to understand its biological mechanisms and improve clinical decision-making. Radiomics, a promising quantitative image analysis method that had been successfully used to describe the phenotype of a wide variety of diseases, while it was less reported in AS. The objective of this study was to investigate the feasibility of radiomics-based approach to profile hip involvement in AS.Methods: A total of 167 patients with AS was included. Radiomic features were extracted from pelvis MRI after image preprocessing and feature engineering. Then, we performed unsupervised machine learning method to derive radiomics-based phenotypes. The validation and interpretation of derived phenotypes were conducted from the perspectives of clinical backgrounds and MRI characteristics. The association between derived phenotypes and radiographic outcomes was evaluated by multivariable analysis.Results: 1321 robust radiomic features were extracted and four biologically distinct phenotypes were derived. According to patient clinical backgrounds, phenotype Ⅰ (38, 22.8%) and Ⅱ (34, 20.4%) were labelled as high-risk while phenotype Ⅲ (24, 14.4%) and Ⅳ (71, 42.5%) were at low risk for hip involvement. Consistently, the high-risk phenotypes were associated with higher prevalence of MRI-detected lesion than the low-risk. Moreover, phenotype I had significant acute inflammation signs than phenotype Ⅱ, while phenotype Ⅳ was enthesitis-predominant. Importantly, the derived phenotypes were highly predictive of radiographic outcomes of patients, as the highrisk phenotypes were 3 times more likely to have radiological hip lesion than the lowrisk [27 (58.7%) vs 16 (28.6%); adjusted odds ratio (OR) 2.95 (95% CI 1.10, 7.92)].We confirmed for the first time, the clinical actionability of profiling hip involvement in AS by radiomics method. Four distinct phenotypes of hip involvement in AS were identified and importantly, the high-risk phenotypes could predict structural damage of hip involvement in AS.

    Keywords: Radiomics, Spondylitis, Ankylosing, Hip involvement, machine learning, Magnetic Resonance Imaging

    Received: 07 Apr 2024; Accepted: 12 Aug 2024.

    Copyright: © 2024 Hu, Wang, Ji, Xu, Li, Zhang, Liu, Li, Zhang, Zhu, Lou and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Xin Lou, Department of Radiology, Chinese PLA General Hospital, Beijing, China
    Feng Huang, Department of Rheumatology and Immunology, Chinese PLA General Hospital, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.